Inferring fetal growth restriction as rare, severe, and stable over time

Reduced birthweight is a marker of pathologies that impair growth and also decrease survival. However, fetal growth restriction remains poorly defined. Assuming that birthweight itself has no causal effect on neonatal mortality, we can estimate the features of pathological fetal growth that would be required to produce the observed pattern of weight-specific mortality. Under the simplest possible scenario, we find that at 39-41 weeks, pathological fetal growth restriction affects only about 0.5% of U.S. births, with a neonatal mortality risk up to 220-fold. This surprising concentration of pathology among a tiny subset of babies would account for roughly half of neonatal deaths at term. Moreover, the prevalence of these pathological births appears to have remained relatively stable over recent decades, even as neonatal mortality in the U.S. has declined by 90%. In our model, the decline has been driven by the reduction in baseline mortality (i.e., mortality among babies unaffected by growth pathologies), while the relative risk of death among pathologically grown infants has apparently remained stable. Fetal growth restriction is conventionally regarded as common and preventable. In contrast, our observations suggest that pathological fetal growth is rare and constant over time, perhaps the result of unpreventable stochastic errors in embryonic development. Public health strategies may be more effective by setting aside attempts to increase birthweight, and focusing instead on the discovery and support of factors (unrelated to birthweight) that have produced the striking reductions in neonatal mortality over time.

Automated summary

Reduced birthweight is a marker of pathologies that impair growth and decrease survival. Fetal growth restriction affects a small percentage of births but has a high neonatal mortality risk. The prevalence of these pathological births has remained stable over time, while neonatal mortality has declined. Public health strategies should focus on factors unrelated to birthweight that have contributed to the reductions in neonatal mortality.